"This collaboration will further solidify Biose's position as the world leading CDMO within the LBP space"
By integrating BactoBox® into their manufacturing, Biose is setting a new industrial standard for microbial enumeration. Rapid cell counts in process monitoring help accelerate the path from clinical trials to market authorization for their innovative live biotherapeutics.
Biose Industrie, a leading CDMO specializing in live biotherapeutic products (LBPs), relies on BactoBox® for process development and production. Conducting thousands of measurements annually, they ensure high-quality bacterial cultivation with greater consistency and precision, optimizing biotherapeutic outcomes.